Company intelligence / Profile preview

MedTank

Ownership: Private
Development stage: Other

Overview

MedTank develops generative AI technologies that are transforming medical imaging quality, accelerating drug discovery by generating novel molecular structures and predicting their properties, and enabling personalized patient care through data-driven treatment planning. The company’s technology is positioned to improve diagnostic accuracy in imaging, reduce time/costs in early-stage drug development, and optimize individualized therapies. No direct clinical trial results are reported as it is a technology/platform provider rather than a therapeutic developer.

Therapeutic areas: Other
Modalities: Small moleculeDigital health/AI platform
Industry: Drug Discovery Services

Beyond the preview

Go deeper on MedTank.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedTank.

Explore the full profile